ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,111,000 | +12.2% | 29,500 | -16.9% | 0.76% | +11.7% |
| Q2 2017 | $990,000 | -18.9% | 35,500 | 0.0% | 0.68% | -18.9% |
| Q1 2017 | $1,220,000 | +117.1% | 35,500 | +82.1% | 0.84% | +118.2% |
| Q4 2016 | $562,000 | -9.4% | 19,500 | 0.0% | 0.38% | +9.7% |
| Q3 2016 | $620,000 | +90.8% | 19,500 | +95.0% | 0.35% | +90.8% |
| Q2 2016 | $325,000 | – | 10,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |